Collectively, γ-MCA inhibits steatosis-induced peroxidative injury to ameliorate NASH by targeting FXR/SHP/LXRα/FASN signaling. The gene discussed is NR1H3; the disease is metabolic dysfunction-associated steatohepatitis.